JP2015518368A5 - - Google Patents

Download PDF

Info

Publication number
JP2015518368A5
JP2015518368A5 JP2014557603A JP2014557603A JP2015518368A5 JP 2015518368 A5 JP2015518368 A5 JP 2015518368A5 JP 2014557603 A JP2014557603 A JP 2014557603A JP 2014557603 A JP2014557603 A JP 2014557603A JP 2015518368 A5 JP2015518368 A5 JP 2015518368A5
Authority
JP
Japan
Prior art keywords
seq
binding protein
isolated
antigen binding
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014557603A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015518368A (ja
JP6383665B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SG2013/000057 external-priority patent/WO2013122544A2/en
Publication of JP2015518368A publication Critical patent/JP2015518368A/ja
Publication of JP2015518368A5 publication Critical patent/JP2015518368A5/ja
Application granted granted Critical
Publication of JP6383665B2 publication Critical patent/JP6383665B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014557603A 2012-02-13 2013-02-13 IL‐1β中和ヒトモノクローナル抗体 Active JP6383665B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG201201007-0 2012-02-13
SG2012010070 2012-02-13
PCT/SG2013/000057 WO2013122544A2 (en) 2012-02-13 2013-02-13 IL-1β NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES

Publications (3)

Publication Number Publication Date
JP2015518368A JP2015518368A (ja) 2015-07-02
JP2015518368A5 true JP2015518368A5 (enExample) 2016-03-31
JP6383665B2 JP6383665B2 (ja) 2018-08-29

Family

ID=54261183

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014557603A Active JP6383665B2 (ja) 2012-02-13 2013-02-13 IL‐1β中和ヒトモノクローナル抗体

Country Status (17)

Country Link
US (5) US10167335B2 (enExample)
EP (2) EP3736289A1 (enExample)
JP (1) JP6383665B2 (enExample)
CN (1) CN105431452B (enExample)
CY (1) CY1123519T1 (enExample)
DK (1) DK2814843T3 (enExample)
ES (1) ES2798110T3 (enExample)
HR (1) HRP20200964T1 (enExample)
HU (1) HUE049860T2 (enExample)
LT (1) LT2814843T (enExample)
PL (1) PL2814843T3 (enExample)
PT (1) PT2814843T (enExample)
RS (1) RS60583B1 (enExample)
SG (2) SG11201404850SA (enExample)
SI (1) SI2814843T1 (enExample)
SM (1) SMT202000321T1 (enExample)
WO (1) WO2013122544A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2814843T3 (da) 2012-02-13 2020-06-22 Agency Science Tech & Res IL-ß-NEUTRALISERENDE HUMANE MONOKLONALE ANTISTOFFER
CN106928354B (zh) * 2017-04-25 2020-07-17 长春金赛药业有限责任公司 抗IL-1β单克隆抗体及其应用
KR20200019865A (ko) * 2017-06-22 2020-02-25 노파르티스 아게 암 치료에 사용하기 위한 il-1베타 결합 항체
CN115028723B (zh) * 2019-03-07 2023-08-29 瑞阳(苏州)生物科技有限公司 人IL-1β蛋白结合分子及其编码基因和应用
KR102087743B1 (ko) * 2019-06-10 2020-03-12 을지대학교 산학협력단 IL-1beta에 특이적으로 결합하는 항체 및 그의 용도
UY40097A (es) * 2022-01-07 2023-07-14 Johnson & Johnson Entpr Innovation Inc Materiales y métodos de proteínas de unión a il-1b
WO2025006936A2 (en) * 2023-06-29 2025-01-02 University Of Maine System Board Of Trustees Methods and compositions for fire-fighting
WO2025147459A1 (en) 2024-01-04 2025-07-10 Nano Precision Medical, Inc. Stabilization of peptides and proteins in implantable devices and formulations

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859205A (en) * 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
DK0769054T3 (da) 1994-07-05 2000-11-13 Steeno Res Group As Immunmodulatorer
DE19742706B4 (de) 1997-09-26 2013-07-25 Pieris Proteolab Ag Lipocalinmuteine
IL127127A0 (en) 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
US6818418B1 (en) 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
US7115396B2 (en) 1998-12-10 2006-10-03 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
US20030007972A1 (en) 1999-02-24 2003-01-09 Edward Tobinick Cytokine antagonists and other biologics for the treatment of bone metastases
GB0001448D0 (en) 2000-01-21 2000-03-08 Novartis Ag Organic compounds
GB0020685D0 (en) * 2000-08-22 2000-10-11 Novartis Ag Organic compounds
CA2421447C (en) 2000-09-08 2012-05-08 Universitat Zurich Collections of repeat proteins comprising repeat modules
ES2567198T3 (es) 2003-01-24 2016-04-20 Applied Molecular Evolution, Inc. Antagonistas de la IL-1 beta humana
GB0303337D0 (en) 2003-02-13 2003-03-19 Celltech R&D Ltd Biological products
ATE416190T1 (de) 2003-07-04 2008-12-15 Affibody Ab Polypeptide mit bindungsaffinität für her2
AU2003275958A1 (en) 2003-08-25 2005-03-10 Pieris Proteolab Ag Muteins of tear lipocalin
JP5006651B2 (ja) 2003-12-05 2012-08-22 ブリストル−マイヤーズ スクウィブ カンパニー 2型血管内皮増殖因子受容体の阻害剤
WO2006081139A2 (en) * 2005-01-26 2006-08-03 Abgenix, Inc. Antibodies against interleukin-1 beta
EP2163562B1 (en) 2005-06-21 2013-09-18 XOMA Technology Ltd. IL-1beta binding antibodies and fragments thereof
TWI395754B (zh) * 2006-04-24 2013-05-11 Amgen Inc 人類化之c-kit抗體
EP1958957A1 (en) 2007-02-16 2008-08-20 NascaCell Technologies AG Polypeptide comprising a knottin protein moiety
CN102655880A (zh) 2009-10-15 2012-09-05 雅培制药有限公司 Il-1结合蛋白
WO2012121679A1 (en) 2011-03-09 2012-09-13 Agency For Science, Technology And Research Method of modulating phenotype of a renal cell cancer-associated monocyte or macrophage
TWI588156B (zh) * 2011-03-28 2017-06-21 賽諾菲公司 具有交叉結合區定向之雙重可變區類抗體結合蛋白
DK2814843T3 (da) 2012-02-13 2020-06-22 Agency Science Tech & Res IL-ß-NEUTRALISERENDE HUMANE MONOKLONALE ANTISTOFFER
WO2016008851A1 (en) 2014-07-14 2016-01-21 Boehringer Ingelheim International Gmbh Anti-il-1b antibodies
AU2016261770B2 (en) 2015-05-12 2022-06-02 Drexel University Compounds and compositions useful for treating or preventing cancer metastasis, and methods using same
CN108025051B (zh) 2015-07-29 2021-12-24 诺华股份有限公司 包含抗pd-1抗体分子的联合疗法
US10397741B2 (en) 2016-11-11 2019-08-27 Shoreline Tracking Systems, LLC System and method for service tracking
WO2018235056A1 (en) 2017-06-22 2018-12-27 Novartis Ag Il-1beta binding antibodies for use in treating cancer
KR20200019865A (ko) 2017-06-22 2020-02-25 노파르티스 아게 암 치료에 사용하기 위한 il-1베타 결합 항체
WO2020039401A1 (en) 2018-08-24 2020-02-27 Novartis Ag Treatment comprising il-1βeta binding antibodies and combinations thereof

Similar Documents

Publication Publication Date Title
JP2015518368A5 (enExample)
JP2023061927A5 (enExample)
RU2020120539A (ru) Композиции для ингибирования masp-2-зависимой активации комплемента
JP2008542278A5 (enExample)
ME02371B (me) Sastojci i postupci za dijagnstikovanje i tretman raka
JP2012525829A5 (enExample)
JP2012500020A5 (enExample)
JP2020502271A5 (enExample)
JP2018521638A5 (enExample)
FI3922645T3 (fi) Pro-/latentin myostatiinin vasta-aineita ja niiden käyttötapoja
JP2010526028A5 (enExample)
JP2020509756A5 (enExample)
NZ602892A (en) Antibodies that bind human cd27 and uses thereof
RU2015141428A (ru) Антитела, связывающие il-4 и/или il-13, и их применение
JP2009529920A5 (enExample)
JP2017113028A5 (enExample)
JP2018504105A5 (enExample)
JP2014526898A5 (enExample)
JP2013519364A5 (enExample)
JP2017534577A5 (enExample)
JP2015529641A5 (enExample)
RU2011110169A (ru) Антитела против ccr2
TW201031421A (en) IL-1 binding proteins
RU2016137110A (ru) Антитела к компоненту комплемента с5
HRP20181087T1 (hr) Pripravak i postupak dijagnostike i liječenja bolesti povezanih s degeneracijom neurita